News
Jyong Biotech Ltd. (Nasdaq: MENS), a science-driven biotechnology company committed to developing innovative botanical drugs for urinary system diseases, visits the Nasdaq MarketSite in Times ...
Key Highlights and Developments This profitability inflection point achievement follows a period of rapid and decisive operational restructuring, during which Trinity Biotech consolidated and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback